Union Commerce and Industry Minister Piyush Goyal has invited international pharmaceutical companies to partner with India, saying the country's drug industry has the potential to double in size over the next five years. Speaking at a major pharmaceutical sector event in New Delhi, the minister highlighted India's growing role in global healthcare and called for stronger international cooperation in research, manufacturing, and innovation.

The announcement reflects India's ambition to move beyond its traditional strength in generic medicines and become a larger force in pharmaceutical innovation. For many years, the country has been known as the "pharmacy of the world" because of its ability to produce affordable medicines for millions of people. Now, policymakers want the sector to expand into advanced drug development, biotechnology, research, and new healthcare technologies.

According to the minister, the domestic pharmaceutical market is currently valued at around 60 billion dollars and could reach approximately 120 billion dollars within five years if growth continues at the expected pace. This projection is based on rising healthcare demand, increasing investment, expanding exports, and stronger innovation capabilities across the industry.

One of the key messages delivered during the event was that India wants to become more than just a manufacturing centre. The government is encouraging the development of new medicines, advanced treatments, and cutting-edge healthcare solutions. Officials believe that a combination of scientific talent, a large consumer base, and supportive policies can help create a stronger innovation ecosystem.

The country's healthcare sector already plays a vital role in the global market. Indian companies supply medicines to numerous nations and are trusted by healthcare systems around the world. Affordable generic drugs produced in the country help millions of patients access treatment at lower costs. This reputation has given the industry a strong foundation for future expansion.

Another major advantage is India's position in vaccine production. A large share of global vaccine demand is met through manufacturing facilities located in the country. During the COVID-19 pandemic, domestic companies supplied medicines and vaccines to many developing nations, strengthening India's image as a reliable healthcare partner.

The minister also stressed that trust remains one of the strongest assets of the sector. Manufacturing standards have increasingly aligned with international requirements, helping Indian products gain acceptance in major markets. The nation also hosts a large number of pharmaceutical facilities approved by international regulators, reflecting confidence in production quality.

Innovation was another important theme of the speech. Government initiatives are encouraging research activity, patent development, and scientific collaboration. Rising patent filings and support programs for biotechnology are intended to help create new products that can compete globally. These efforts are part of a broader strategy to make the economy more knowledge-driven and technology-focused.

The invitation to overseas drug makers also reflects India's growing economic confidence. Despite global uncertainties, including geopolitical conflicts and trade challenges, the country's economy has continued to grow at a strong pace. This stability has helped attract interest from international investors seeking long-term opportunities in expanding markets.

Partnerships with foreign businesses could bring several benefits. International companies can contribute advanced technologies, research expertise, and investment. In return, they gain access to one of the world's largest healthcare markets, a skilled workforce, and an extensive manufacturing network. Such cooperation can create jobs, increase exports, and improve access to modern treatments.

The government's emphasis on collaboration also highlights the changing nature of healthcare. Modern medical challenges often require countries to work together on research, disease prevention, and treatment development. Strong international partnerships can help accelerate discoveries and improve healthcare outcomes for people across different regions.

For patients, continued growth in the pharmaceutical industry could lead to greater availability of medicines, improved treatment options, and increased investment in healthcare services. Expanding production capacity and research capabilities may also strengthen the country's ability to respond to future health emergencies.

The minister's call for global engagement is ultimately about positioning India as a leading healthcare and innovation hub. By combining affordable manufacturing with advanced research, the country hopes to play an even larger role in improving global health while supporting economic growth at home.

Invitation to international pharmaceutical companies comes at an important moment for the sector. Demand for healthcare continues to rise worldwide, and nations are searching for reliable partners in medicine production and innovation. With its large market, scientific talent, manufacturing strength, and growing focus on research, India is seeking to turn this opportunity into long-term progress. If these efforts succeed, the pharmaceutical industry could become one of the strongest drivers of the country's economic and healthcare future.